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Osteoarthritis (OA) is a chronic, degenerative disease with multifactorial 
etiology which constitutes the most common cause of pain and disability in older adults, 
as well as the leading cause of joint replacement surgery. The degradation of articular 
cartilage in osteoarthritis is related to changes in the composition of the extracelular 
matrix and the alteration of protein expression by chondrocytes, the only cell component 
of cartilage, along with well-defined changes in the subchondral and periarticular bone. 
Since the application of therapies based on cells with regenerative potential like 
mesenchymal stem cells (MSCs), progenitor cells with the capacity to differentiate into 
distinct connective tissues including cartilage, represent a promising strategy for the 
treatment of OA, we have searched in this work for altered proteins in bone marrow 
MSCs obtained from osteoarthritis patients using a shotgun approach.  
MSCs protein extracts were prepared from bone marrow aspirates obtained from 
patients undergoing joint replacement as a result of OA as well as from healthy donors, 
without special radiographic signs of OA, in the surgery for the subcapital fracture of 
the hip. Samples were then digested with trypsin and analyzed by LC-MS. A variety of 
software tools (commercial, publicly available and home-made) enabled a 
comprehensive bioinformatic analysis based on the proteins identified. Results highlight 
distinctive functional categories and interaction networks which suggest a diminished 
differentiation and regenerative potential of MSCs in patients with OA. 
 
